Clinical Trials Browser

Leukemia, Myeloid, Chronic-Phase × Pharmaceutical Preparations × 90 days × Clear all

NCT03817398 2026-05-20

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase